Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Mar-24 8:10 PM View:  | Faga Daniel CEO Director | Anaptysbio, Inc (ANAB) | 26-Mar-24 | Payment of Exercise | 347,441 | $21.60 | $7,504,730.00 | (46%) 749.09K to 401.65K | |
| 26-Mar-24 8:10 PM View: | Faga Daniel CEO Director | Anaptysbio, Inc (ANAB) | 25-Mar-24 | Sale | 3,000 | $21.42 | $64,267.50 | (< 1%) 752.09K to 749.09K | |
| 26-Mar-24 8:10 PM View: | Faga Daniel CEO Director | Anaptysbio, Inc (ANAB) | 22-Mar-24 | Sale | 145,940 | $22.78 | $3,325,180.00 | (16%) 898.03K to 752.09K | |
| 21-Feb-24 5:38 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 16-Feb-24 | Planned Option Sale | 5,000 | $25.00 | $125,000.00 | (61%) 8.24K to 3.24K | |
| 21-Feb-24 5:38 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 16-Feb-24 | Option Exercise | 5,000 | $14.02 | $70,100.00 | 154% 3.24K to 8.24K | |
| 01-Feb-24 5:27 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 30-Jan-24 | Sale (Planned) | 3,065 | $23.63 | $72,425.30 | (76%) 4.03K to 0.96K | |
| 09-Jan-24 7:06 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 08-Jan-24 | Option Sale | 2,180 | $21.81 | $47,545.80 | (35%) 6.21K to 4.03K | |
| 09-Jan-24 7:07 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 08-Jan-24 | Option Sale | 2,305 | $21.81 | $50,272.00 | (42%) 5.54K to 3.24K | |
| 09-Jan-24 7:08 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 08-Jan-24 | Option Sale | 2,554 | $21.81 | $55,702.70 | (20%) 12.67K to 10.12K | |
| 09-Jan-24 7:05 PM View: | Faga Daniel CEO Director | Anaptysbio, Inc (ANAB) | 08-Jan-24 | Option Sale | 6,866 | $21.81 | $149,747.00 | (< 1%) 904.89K to 898.03K | |
| 09-Jan-24 7:06 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 06-Jan-24 | Option Exercise | 5,245 | -- | -- | 544% 0.96K to 6.21K | |
| 09-Jan-24 7:08 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 06-Jan-24 | Option Exercise | 6,145 | -- | -- | 94% 6.53K to 12.67K | |
| 09-Jan-24 7:05 PM View: | Faga Daniel CEO Director | Anaptysbio, Inc (ANAB) | 06-Jan-24 | Option Exercise | 17,850 | -- | -- | 2% 887.04K to 904.89K | |
| 09-Jan-24 7:07 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 06-Jan-24 | Option Exercise | 5,545 | -- | -- | 100% 0 to 5.54K | |
| 27-Nov-23 4:03 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 22-Nov-23 | Sale (Planned) | 882 | $14.19 | $12,515.60 | (100%) 0.88K to 0 | |
| 18-Sep-23 6:13 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 18-Sep-23 | Planned Option Sale | 3,895 | $19.32 | $75,232.30 | (82%) 4.78K to 0.88K | |
| 18-Sep-23 6:12 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 18-Sep-23 | Planned Option Sale | 3,895 | $19.32 | $75,236.60 | (80%) 4.86K to 0.96K | |
| 18-Sep-23 6:14 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 14-Sep-23 | Option Sale | 2,105 | $19.48 | $41,005.40 | (24%) 8.63K to 6.53K | |
| 18-Sep-23 6:12 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 14-Sep-23 | Option Exercise | 6,000 | -- | -- | 622% 0.96K to 6.96K | |
| 18-Sep-23 6:13 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 14-Sep-23 | Option Sale | 2,105 | $19.48 | $41,005.40 | (31%) 6.88K to 4.78K | |
| 18-Sep-23 6:12 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 14-Sep-23 | Option Sale | 2,105 | $19.48 | $41,005.40 | (30%) 6.96K to 4.86K | |
| 18-Sep-23 6:14 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 14-Sep-23 | Option Exercise | 6,000 | -- | -- | 228% 2.63K to 8.63K | |
| 18-Sep-23 6:13 PM View: | Loumeau Eric J Chief Legal Officer | Anaptysbio, Inc (ANAB) | 14-Sep-23 | Option Exercise | 6,000 | -- | -- | 680% 0.88K to 6.88K | |
| 09-Aug-22 6:03 PM View: | Loumeau Eric J COO, General Counsel | Anaptysbio, Inc (ANAB) | 08-Aug-22 | Sale (Planned) | 523 | $25.00 | $13,075.00 | (100%) 0.52K to 0 | |
| 10-Jun-22 5:22 PM View: | Loumeau Eric J COO, General Counsel | Anaptysbio, Inc (ANAB) | 08-Jun-22 | Planned Option Sale | 2,500 | $24.00 | $60,000.00 | (83%) 3.02K to 0.52K | |
| 10-Jun-22 5:22 PM View: | Loumeau Eric J COO, General Counsel | Anaptysbio, Inc (ANAB) | 08-Jun-22 | Option Exercise | 2,500 | $14.02 | $35,050.00 | 478% 0.52K to 3.02K | |
| 20-May-22 4:42 PM View: | Loumeau Eric J COO, General Counsel | Anaptysbio, Inc (ANAB) | 18-May-22 | Sale (Planned) | 1,146 | $20.50 | $23,493.00 | (69%) 1.67K to 0.52K | |
| 09-May-22 6:04 AM View: | Ecor1 Capital, LLC 10% Owner | Anaptysbio, Inc (ANAB) | 05-May-22 | Private Purchase | 668,237 | $21.63 | $14,454,000.00 | 4% 15.04M to 15.71M | |
| 09-May-22 6:04 AM View: | Ecor1 Capital, LLC 10% Owner | Anaptysbio, Inc (ANAB) | 05-May-22 | Sale | 668,237 | $21.63 | $14,454,000.00 | (4%) 15.71M to 15.04M | |
| 23-Mar-22 4:48 PM View: | Faga Daniel Interim CEO Director | Anaptysbio, Inc (ANAB) | 21-Mar-22 | Grant | 887,043 | -- | -- | 100% 0 to 887.04K | |
| 22-Dec-21 6:42 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 20-Dec-21 | Option Exercise | 36,645 | $1.12 | $41,042.40 | 53% 68.6K to 105.25K | |
| 22-Dec-21 6:42 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 20-Dec-21 | Market Option Sale (Planned) | 36,645 | $35.57 | $1,303,560.00 | (35%) 105.25K to 68.6K | |
| 17-Nov-21 5:20 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 15-Nov-21 | Grant | 964 | $22.03 | $21,236.90 | 1% 67.64K to 68.6K | |
| 17-Nov-21 5:18 PM View: | Loumeau Eric J COO, General Counsel | Anaptysbio, Inc (ANAB) | 15-Nov-21 | Grant | 523 | $22.03 | $11,521.70 | 100% 0 to 0.52K | |
| 17-Nov-21 5:22 PM View: | Lizzul Paul F. Chief Medical Officer | Anaptysbio, Inc (ANAB) | 15-Nov-21 | Grant | 964 | $22.03 | $21,236.90 | 100% 0 to 0.96K | |
| 17-Nov-21 5:16 PM View: | Mulroy Dennis Chief Financial Officer | Anaptysbio, Inc (ANAB) | 15-Nov-21 | Grant | 964 | $22.03 | $21,236.90 | 100% 0 to 0.96K | |
| 05-Nov-21 6:24 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 05-Nov-21 | Option Exercise | 14,302 | $1.12 | $16,018.20 | 21% 67.64K to 81.94K | |
| 05-Nov-21 6:24 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 05-Nov-21 | Market Option Sale (Planned) | 14,302 | $35.00 | $500,570.00 | (17%) 81.94K to 67.64K | |
| 05-Nov-21 6:23 PM View: | Loumeau Eric J COO, General Counsel | Anaptysbio, Inc (ANAB) | 04-Nov-21 | Market Option Sale (Planned) | 5,000 | $35.00 | $175,000.00 | (100%) 5.0K to 0 | |
| 05-Nov-21 6:24 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 04-Nov-21 | Option Exercise | 6,059 | $1.12 | $6,786.08 | 9% 67.64K to 73.69K | |
| 05-Nov-21 6:24 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 04-Nov-21 | Market Option Sale (Planned) | 6,059 | $35.00 | $212,065.00 | (8%) 73.69K to 67.64K | |
| 05-Nov-21 6:23 PM View: | Loumeau Eric J COO, General Counsel | Anaptysbio, Inc (ANAB) | 04-Nov-21 | Option Exercise | 5,000 | $17.09 | $85,450.00 | 100% 0 to 5.0K | |
| 02-Nov-21 5:53 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 01-Nov-21 | Option Exercise | 36,646 | $1.12 | $41,043.50 | 54% 67.64K to 104.28K | |
| 02-Nov-21 5:53 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 01-Nov-21 | Market Option Sale (Planned) | 36,646 | $32.31 | $1,184,110.00 | (35%) 104.28K to 67.64K | |
| 28-Oct-21 7:54 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 26-Oct-21 | Option Exercise | 15,993 | $1.12 | $17,912.20 | 24% 67.64K to 83.63K | |
| 28-Oct-21 7:54 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 26-Oct-21 | Market Option Sale (Planned) | 15,993 | $30.00 | $479,790.00 | (19%) 83.63K to 67.64K | |
| 21-Sep-21 10:00 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 17-Sep-21 | Option Exercise | 10,000 | $1.12 | $11,200.00 | 17% 57.64K to 67.64K | |
| 13-May-21 4:50 PM View: | Suria Hamza President, CEO Director | Anaptysbio, Inc (ANAB) | 12-May-21 | Option Exercise | 10,000 | $1.12 | $11,200.00 | 21% 47.64K to 57.64K | |
| 04-May-21 4:51 PM View: | Ecor1 Capital, LLC Director 10% Owner | Anaptysbio, Inc (ANAB) | 04-May-21 | Market Purchase | 165,000 | $23.25 | $3,835,760.00 | 2% 7.36M to 7.52M | 2% |
| 04-May-21 4:51 PM View: | Ecor1 Capital, LLC Director 10% Owner | Anaptysbio, Inc (ANAB) | 03-May-21 | Market Purchase | 20,800 | $23.31 | $484,873.00 | < 1% 7.33M to 7.36M | 2% |
